157327-42-9

Basic information

• Product Name: (E)-TERT-BUTYL 3-((DIMETHYLAMINO)METHYLENE)-4-OXOPYRROLIDINE-1-CARBOXYLATE
• Synonyms: (E)-TERT-BUTYL 3-((DIMETHYLAMINO)METHYLENE)-4-OXOPYRROLIDINE-1-CARBOXYLATE;3-(diMethylaMinoMethylidene)-4-oxo-1-pyrrolidinecarboxylic acid tert-butyl ester;3-DiMethylaMinoMethylene-4-oxo-pyrrolidine-1-carboxylic acid tert-butyl ester;tert-Butyl 3-((diMethylaMino)Methylene)-4-oxopyrrolidine-1-carboxylate;tert-butyl (Z)-3-((dimethylamino)methylene)-4-oxopyrrolidine-1-carboxylate;tert-Butyl 3-((dimethylamino)methylene)-4-oxo...;3-((dimethylamino)methylene)-4-oxopyrrolidine-1-carboxylate
• CAS NO: 157327-42-9
• Molecular Formula: C₁₂H₂₀N₂O₃
• Molecular Weight: 240.2988
• Mol File: 157327-42-9.mol
• Article Data: 19

Chemical Properties

• Boiling Point: 341.0±42.0 °C(Predicted)
• Appearance: /
• Density: 1.175±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 5.25±0.20(Predicted)
• CAS DataBase Reference: (E)-TERT-BUTYL 3-((DIMETHYLAMINO)METHYLENE)-4-OXOPYRROLIDINE-1-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-TERT-BUTYL 3-((DIMETHYLAMINO)METHYLENE)-4-OXOPYRROLIDINE-1-CARBOXYLATE(157327-42-9)
• EPA Substance Registry System: (E)-TERT-BUTYL 3-((DIMETHYLAMINO)METHYLENE)-4-OXOPYRROLIDINE-1-CARBOXYLATE(157327-42-9)

Safety Data

• Hazardous Substances Data: 157327-42-9(Hazardous Substances Data)

Usage

General Description

(E)-Tert-butyl 3-((dimethylamino)methylene)-4-oxopyrrolidine-1-carboxylate is a chemical compound with the molecular formula C14H24N2O3. It is a derivative of pyrrolidine carboxylate and belongs to the class of organic compounds known as tertiary carboxylic acid esters. (E)-TERT-BUTYL 3-((DIMETHYLAMINO)METHYLENE)-4-OXOPYRROLIDINE-1-CARBOXYLATE is commonly used in the pharmaceutical industry, particularly in the production of drugs and medications. Its specific properties and uses may vary depending on the application and the synthesis methods used.

Upstream product

• 298181-77-8 tert-butyl 3-oxo-2,3-dihydro-1H-pyrrole-1-carboxylate 
• 68-12-2 N,N-dimethyl-formamide 
• 101385-93-7 3-oxo-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 4637-24-5 N,N-dimethyl-formamide dimethyl acetal 

Downstream Products

• 905274-03-5 2-Trifluoromethyl-5,7-dihydro-pyrrolo[3,4-d]pyrimidine-6-carboxylic acid tert-butyl ester 
• 1027385-29-0 tert-butyl [(1S,2R,5S)-5-(2-methyl-6,8-dihydro-7H-pyrazolo[1,5-a]pyrrolo[3,4-e]pyrimidin-7-yl)-2-(2,4,5-trifluorophenyl)cyclohexyl]carbamate 
• 1226781-82-3 tert-butyl 2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylate 
• 157327-52-1 2-amino-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine dihydrochloride 
• 1160995-19-6 tert-butyl 2-methyl-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxylate 

Relevant articles and documents

Structure-activity-relationship of amide and sulfonamide analogs of omarigliptin

A series of novel substituted-[(3R)-amino-2-(2,5-difluorophenyl)]tetrahydro-2H-pyran analogs have been prepared and evaluated as potent, selective and orally active DPP-4 inhibitors. These efforts lead to the discovery of a long acting DPP-4 inhibitor, omarigliptin (MK-3102), which recently completed phase III clinical development and has been approved in Japan.

Guanidine derivative and application thereof

The invention relates to a guanidine derivative serving as a VAP-1 inhibitor and application of the guanidine derivative, and further relates to a pharmaceutical composition containing the compound. The compound or the pharmaceutical composition can be us

Bicyclic inhibitors of histone deacetylase

Provided herein are compounds and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of conditions associated with inhibition of HDAC (e.g., HDAC2).